These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9151831)

  • 41. Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly.
    Yu XF; Dawson L; Tian CJ; Flexner C; Dettenhofer M
    J Virol; 1998 Apr; 72(4):3412-7. PubMed ID: 9525672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.
    Bukrinskaya AG; Ghorpade A; Heinzinger NK; Smithgall TE; Lewis RE; Stevenson M
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):367-71. PubMed ID: 8552640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
    Liu H; Wu X; Xiao H; Conway JA; Kappes JC
    J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
    Poon DT; Li G; Aldovini A
    J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production.
    Freed EO; Orenstein JM; Buckler-White AJ; Martin MA
    J Virol; 1994 Aug; 68(8):5311-20. PubMed ID: 8035531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
    Murakami T; Ablan S; Freed EO; Tanaka Y
    J Virol; 2004 Jan; 78(2):1026-31. PubMed ID: 14694135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second-site revertants of a simian immunodeficiency virus gp41 mutant defective in envelope glycoprotein incorporation.
    Celma CC; Manrique JM; Hunter E; Affranchino JL; González SA
    AIDS Res Hum Retroviruses; 2004 Jul; 20(7):733-41. PubMed ID: 15307919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells.
    Owens RJ; Dubay JW; Hunter E; Compans RW
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3987-91. PubMed ID: 2023946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.
    Hermida-Matsumoto L; Resh MD
    J Virol; 2000 Sep; 74(18):8670-9. PubMed ID: 10954568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop.
    Kong LB; An D; Ackerson B; Canon J; Rey O; Chen IS; Krogstad P; Stewart PL
    J Virol; 1998 May; 72(5):4403-7. PubMed ID: 9557731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation.
    Kirschman J; Qi M; Ding L; Hammonds J; Dienger-Stambaugh K; Wang JJ; Lapierre LA; Goldenring JR; Spearman P
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29212940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues.
    Cimarelli A; Luban J
    J Virol; 2000 Aug; 74(15):6734-40. PubMed ID: 10888611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.
    Paxton W; Connor RI; Landau NR
    J Virol; 1993 Dec; 67(12):7229-37. PubMed ID: 8230445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of mutations in the nucleocapsid protein (NCp7) upon Pr160(gag-pol) and tRNA(Lys) incorporation into human immunodeficiency virus type 1.
    Huang Y; Khorchid A; Wang J; Parniak MA; Darlix JL; Wainberg MA; Kleiman L
    J Virol; 1997 Jun; 71(6):4378-84. PubMed ID: 9151827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17.
    Cannon PM; Matthews S; Clark N; Byles ED; Iourin O; Hockley DJ; Kingsman SM; Kingsman AJ
    J Virol; 1997 May; 71(5):3474-83. PubMed ID: 9094619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of host cell MAPK/ERK-2 incorporation into lentivirus particles: characterization of the interaction between MAPK/ERK-2 and proline-rich-domain containing capsid region of structural protein Gag.
    Gupta P; Singhal PK; Rajendrakumar P; Padwad Y; Tendulkar AV; Kalyanaraman VS; Schmidt RE; Srinivasan A; Mahalingam S
    J Mol Biol; 2011 Jul; 410(4):681-97. PubMed ID: 21762808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.
    Qi M; Chu H; Chen X; Choi J; Wen X; Hammonds J; Ding L; Hunter E; Spearman P
    Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7575-80. PubMed ID: 26034275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.
    Pettit SC; Moody MD; Wehbie RS; Kaplan AH; Nantermet PV; Klein CA; Swanstrom R
    J Virol; 1994 Dec; 68(12):8017-27. PubMed ID: 7966591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.